Related Experiment Video
Updated: Dec 25, 2025

07:43
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.9K
[Erratum: Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version)]
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|March 27, 2020
Abstract:
Erratum: Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version) Zhou CC, Wang J, Bu H, et al. Zhongguo Fei Ai Za Zhi, 2020, 23(2): 65-76. In the version of this article initially published, error appeared on page 65. The author address should be "400037 ,()". And another error appeared on page 66. The first sentence in part 1 should be "(age standardized rate, ASR)31.5/1014.6/10".
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

